Highlights

• First purchase order secured with global footwear company Flux Footwear for graphene-enhanced athletic and leisure footwear
• US-based customer becomes the third footwear client in First Graphene’s growing global portfolio to leverage PureGRAPH^®‘s performance benefits
• Purchase order marks FGR’s first commercial production application in global sports shoe market, valued at more than US$150 billion^[1]

SYDNEY, Oct. 7, 2026 /PRNewswire/ — First Graphene Limited (ASX: FGR; “First Graphene” or “the Company”) (FRA:M11) (OTCQB:FGPHF) is pleased to announce it has secured its first purchase order from US-based footwear company Flux Footwear (“Flux”).

Flux Footwear will incorporate PureGRAPH^® into its athletic and leisure footwear range, delivering strength and durability enhancements to the brand’s Graphene XT performance gym shoes.

The purchase order will be the Company’s first production application within the sporting and athletic footwear sector, building on previously announced success in the work and safety footwear industry.

Following recent development work, PureGRAPH^® was selected for use across Flux’s graphene-enhanced footwear range and will progressively replace existing graphene models as production requirements increase.

Driving performance with advanced materials

Flux is an innovative US performance footwear company already using graphene as part of its product innovation strategy through its Graphene-Pro™ footwear range.

Graphene is used in high-wear areas of the outsole to enhance durability, abrasion and tear resistance, grip and flexibility without unnecessary additional weight. PureGRAPH^®‘s proven performance benefits will ensure the quality of Flux’s footwear range is maintained.

Flux has a well-established global customer base, delivering graphene-enhanced footwear primarily into the US market.

The first production order with First Graphene will establish a pathway for penetration into these markets through ongoing PureGRAPH^® supply as Flux progresses production of its graphene-enhanced footwear.

Building on established success

The production order with Flux builds on First Graphene’s established technical and commercial experience in the footwear segment.

The Company has previously progressed PureGRAPH^® through development, independent testing and commercial production in work and safety footwear, including collaborations with Australian safety footwear manufacturer Steel Blue and Indonesian mining work boot manufacturer PT Alasmas Berkat Utama.

PureGRAPH^® was successfully incorporated into both types of footwear, targeting improvements in abrasion resistance, tear strength and durability, and subsequently progressed into commercial production.

The Flux order represents the next evolution of this established application, extending First Graphene’s formulation knowledge and commercial experience from industrial and safety footwear into the substantially larger sporting, athletic and leisure footwear segment.

While this initial order is not itself financially material to the Company, importantly it reinforces the Company’s ability to transfer an established PureGRAPH^® application into a new customer, product category and geographic market, which is an important component of First Graphene’s commercialisation strategy.

The global sports shoes market is anticipated to be valued at more than US$212 billion by 2035¹, representing a strong increase in demand for more durable and longer-lasting sports shoes.

First Graphene Managing Director and CEO Michael Bell said:

“The first production order for Flux Footwear represents another important commercial milestone for First Graphene, delivering a new revenue stream while reinforcing the Company’s growing market presence built through years of strategic partnerships and product development.

This commercial agreement with a globally renowned company will provide potential pathways to recurring PureGRAPH^® production demand while also further expanding our presence in the US.

Our collaboration with Flux also reflects the overarching rising global demand for more durable, high-performing footwear, as consumers and manufacturers increasingly prioritise longevity, performance and sustainability.

Most importantly, this progression from development and validation to production order and potential recurring revenue is exactly what First Graphene is focused on delivering from our commercial strategy.

We look forward to working with Flux as it continues to develop innovative and high-performing footwear using our proven PureGRAPH^® products.”

This announcement has been approved by the Chairman.

References

New partnership to broaden the reach of Taiwan’s award-winning single malt across Australia

TAIPEI, Oct. 7, 2026 /PRNewswire/ — Kavalan, Taiwan’s globally celebrated single malt whisky distillery, has appointed Cerbaco Distribution to expand its presence across Australia.

Cerbaco, a family-owned premium spirits specialist with four decades of experience, will lead national distribution and bring Kavalan to more Australian retailers, bars and whisky drinkers.

King Car Chairman Mr. YT Lee said: “This is an exciting new partnership for Kavalan in a sophisticated whisky market that increasingly values quality, provenance and discovery. Cerbaco’s deep expertise in premium aged spirits and commitment to education make it an ideal partner to take our story to more Australian whisky drinkers.”

Cerbaco General Manager Max Lennox said: “Kavalan is one of the most decorated distilleries in the world, and it still surprises Australian whisky drinkers when they discover where it comes from. That is the opportunity. Our job is to put it in front of the retailers and drinkers who set the direction of this market, and let the whisky do the rest. Taiwan has been making whisky at this level for over twenty years, and Australia has largely missed it. Partnering with Kavalan to change that is a genuine privilege.”

Taiwan’s subtropical climate shapes Kavalan’s fruit-forward character, while its use of different casks brings variety to the range. Kavalan is particularly known for its sherry cask whiskies, with notes of dried fruit, chocolate and spice. LÁN Single Malt Whisky shows another side of the distillery. Matured in ex-bourbon, ruby port and STR vinho casks, it combines floral and fruit notes with vanilla and caramel sweetness. Through Cerbaco’s nationwide network, Australian drinkers will have more opportunities to explore these different expressions.

Founded in 1985, Cerbaco represents more than 1,500 spirits and has a sales network covering every Australian state and territory. Cerbaco represents some of the world’s finest spirits across every major category, from Armagnac to Cognac, whisky, tequila and vodka, liqueurs and aperitifs, calvados and much more.

For information on Kavalan’s availability in Australia or trade enquiries, please contact Cerbaco Distribution:

Website: https://www.cerbaco.com.au/

Commercial Manager: Josie Petrolo (Josie@cerbaco.com.au)

Media Contact: Wendy Wang (wendywa@kingcar.com.tw)

About Kavalan Whisky

Kavalan Distillery in Yilan County has been pioneering the art of single malt whisky in Taiwan since 2005. Our whisky, aged in intense humidity and heat, sources the crystal meltwaters of Snow Mountain and is enhanced by sea and mountain breezes. These conditions combine to create Kavalan’s signature creaminess. Taking Yilan County’s old name, our distillery is backed by more than 45 years of beverage-making under parent company, King Car Group. We have collected 1,000 gold or higher awards from the industry’s most competitive contests.

• Strategic Milestone: Official opening of the Robotics Training, Data and Experience Center in Singapore to support humanoid training, workflow testing, and customer demonstrations.
• Tapping a US$68.1 Billion Market: Capitalizing on the global service robotics market—estimated at US$68.1 billion in 2026 and projected to reach US$107.8 billion by 2030—alongside the US$5.41 billion humanoid robot sector.
• Commercial Pathway: Designed to evaluate Robotics-as-a-Service (“RaaS”), robot leasing, and managed services as potential recurring revenue streams supporting the Company’s 2030 vision.

SINGAPORE, Oct. 7, 2026 /PRNewswire/ — YYForce Inc. (NASDAQ: YFOR) (“YYForce” or the “Company”), a technology-enabled workforce solutions and integrated facility management company, today announced the official opening of its Robotics Training, Data and Experience Center (the “Center”) in Singapore. The facility supports humanoid robot training, operational data collection, workflow testing, and customer demonstrations across hospitality, cleaning, security, delivery, and facility management applications.

The Center is designed to help YYForce translate robotics technologies into practical customer solutions, drawing on its existing workforce and facility management operations. It also supports the Company’s evaluation of Robotics-as-a-Service (“RaaS”), robot leasing, and managed robotic services as potential sources of recurring revenue.

Capitalizing on the US$68.1 Billion Commercial Robotics Opportunity

YYForce believes Singapore offers an attractive environment for robotics adoption as service operators seek to improve productivity, manage manpower constraints, and maintain consistent service quality. In May 2026, the Infocomm Media Development Authority (IMDA), JTC Corporation (JTC), and the Singapore Institute of Technology (SIT) announced a physical AI testbed at Punggol Digital District, planned for later in 2026, with applications including delivery, cleaning, and security patrolling. This initiative provides wider market context; YYForce is not announcing participation in that programme.

Globally, Grand View Research estimates the service robotics market at US$68.1 billion in 2026 and projects it to reach US$107.8 billion by 2030. Separately, MarketsandMarkets estimates the global humanoid robot market at US$5.41 billion in 2026 and projects US$50.27 billion by 2035. These forecasts cover different, potentially overlapping categories and are not additive. They provide industry context, rather than estimates of Singapore demand or YYForce’s addressable revenue.

For the 2026–2031 period, YYForce sees opportunities to evaluate specialized service robots for defined commercial tasks while developing humanoid applications through training and testing. The Company intends to assess deployment opportunities based on task performance, safety, reliability, required human supervision, and customer economics.

Humanoid Training and Operational Data Collection

The Center includes simulated service environments for training and evaluating humanoid robots in selected hotel housekeeping, restroom cleaning, banqueting, and hospitality support workflows. It also supports testing of collaboration among human workers, humanoid robots, and specialized service robots.

Through repeated training and testing, YYForce is collecting operational data relating to navigation, movement, object interaction, task execution, and environmental conditions. Though training and demonstration activities do not establish that humanoid robots can yet perform complete housekeeping or restroom-cleaning duties autonomously, these activities are intended to help evaluate performance and adapt workflows to specific service environments.

Service Robotics and Integrated Security Demonstrations

The Center showcases indoor and outdoor commercial cleaning robots, food and item delivery robots, autonomous security and surveillance robots, swimming pool cleaning robots, humanoid service robots, and other specialized systems. Customers and potential partners can evaluate how these technologies may fit within their operations.

A live Security Command Center, as part of the Center, demonstrates the integration of robotic patrol capabilities, surveillance systems, sensors, cameras, and centralized monitoring. This environment enables YYForce to evaluate how robotic and monitoring technologies can complement security personnel and broader facility management services.

Building a Path to Recurring Robotics Revenue

The Center anticipates to support a structured commercialization pathway: training and data collection, workflow testing, customer demonstrations, proofs of concept, and, where viable, commercial deployment. Potential applications include hotels, commercial buildings, residential developments, retail premises, warehouses, and other service environments.

YYForce is evaluating commercial arrangements that could combine robot access with deployment support, maintenance, monitoring, and human service capabilities. Potential RaaS and leasing models would allow customers to access robotics through recurring arrangements without necessarily purchasing hardware outright. Integrated service contracts could combine people and robots within a single service-delivery model.

The Company believes its existing operating experience can help identify suitable tasks, evaluate customer requirements, and coordinate human-robot workflows. Commercial viability will depend on productivity gains, service quality, deployment and integration costs, maintenance requirements, and the level of human intervention needed.

At this stage, the Company has not yet announced material revenue attributable to these proposed robotics business models. The Center’s opening does not represent an announcement of material robotics orders or contracted recurring revenue. Future commercialization remains subject to customer adoption, technology performance, deployment economics, and other factors.

Supporting the YYForce 2030 Vision

The Center anticipates to support YYForce’s 2030 vision of becoming a Future Workforce Solutions Provider by integrating human talent, AI-enabled technologies, humanoid robots, and specialized autonomous robots. Human workers would continue to perform activities requiring judgment, communication, and flexibility, while suitable robotic systems could support repetitive, physically demanding, and monitoring-intensive tasks.

Chief Executive Officer Commentary

Mike Fu, Chief Executive Officer of YYForce, commented:

“Our objective is to help customers put robotics to work in everyday service operations. Our existing workforce and facility management experience gives us direct insight into the tasks customers need completed and the standards they expect.”

“This center provides a dedicated working environment to train humanoid robots, collect operational data, and evaluate service robots prior to customer deployment. We see clear opportunities to develop recurring service relationships through leasing and managed robotics, while rigorously testing each application against performance and cost requirements.”

“Our 2030 vision brings people, AI, and robotics together to elevate how services are delivered. We will pursue that vision through practical applications and disciplined commercial execution — Forging Forward Together.”

About YYForce Inc.

YYForce Inc. (NASDAQ: YFOR) is a technology-enabled workforce solutions and integrated facility management company focused on how businesses access, manage, and deploy workforce and facility services. The Company is developing an ecosystem combining on-demand workforce technology, integrated facility management, artificial intelligence, automation, humanoid robotics, and specialized service robots to support productivity, operational flexibility, and scalability.

Forward-Looking Statements

This press release contains forward-looking statements, including statements regarding the Company’s robotics strategy, training and data collection activities, potential customer applications, RaaS and leasing models, managed services, recurring revenue opportunities, and YYForce’s 2030 vision, within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company bases these forward-looking statements on its expectations and projections about future events, which the Company derives from the information currently available to it. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. Third-party market forecasts are estimates and may not be realized.

Forward-looking statements involve inherent risks and uncertainties, and the forward-looking events discussed in this press release may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about the Company and a number of factors. These factors include, but are not limited to, customer adoption, technology reliability and safety, integration requirements, data governance, financing and hardware availability, maintenance costs, and deployment economics. There can be no assurance that the Company’s robotics initiatives or proposed commercial models will be successfully implemented or generate material revenue. For a more detailed discussion of risk factors, please refer to the Company’s filings with the Securities and Exchange Commission, including the “Risk Factors” section of the Company’s most recent annual report on Form 20-F, as amended. Readers should also consider the risks described in the Company’s filings with the U.S. Securities and Exchange Commission. YYForce undertakes no obligation to update these statements except as required by applicable law.

Investor Contact
Jason Zhi Yong Phua, Chief Financial Officer
YYForce Inc.
enquiries@yyforce.ai

Investor Relations Contact
Piacente Financial Communications
yfor@thepiacentegroup.com

Market Sources

[1] JTC, Singapore Government and Eight Industry Leaders to Research, Test and Deploy Physical AI in Punggol Digital District, May 20, 2026.
[2] Grand View Research, Service Robotics Market 2024–2030, public report summary accessed October 2, 2026.
[3] MarketsandMarkets, Humanoid Robot Market — Global Forecast to 2035, July 2026.

CAMBRIDGE, England, Oct. 7, 2026 /PRNewswire/ — Cambridge Heartwear® Limited (www.camheartwear.com) has secured a landmark £184 million tender with the National Health Service (NHS) of the UK for HeartSense®, the world’s first medical-grade, multi-channel, portable, wirelessly charged ECG wearable straight to one’s mobile phone, representing a significant advancement in global Medical technology, AI application and cardiovascular diagnostics. 

The agreement with the UK National Health Service Supply chain enables the deployment of advanced cardiac monitoring technology across primary and secondary care and civil service departments, empowering patients to diagnose heart rhythm problems whenever and wherever they are to prevent heart failure and strokes earlier, reduce waiting times and support a more preventative approach to Heart Disease, which can take place in the comfort of their own homes. 

HeartSense® is the world’s first wearable to combine diagnostic-grade multi-channel ECG monitoring, adaptive artificial intelligence and wireless charging in a single device. Manufactured to bridge the gap in women’s cardiovascular care with its ergonomic design, the technology gives healthcare professionals and patients access to continuous, real-time ECG data on a mobile phone. giving you back the control of your health at every stage. 

Engineered in Cambridge and manufactured in Britain, HeartSense® has been developed to help identify cardiovascular disease and stroke risk before conditions become acute. Its proprietary engineering and AI technology with (86 patents ) support earlier intervention, enabling clinicians to make more informed decisions and improve patient outcomes. 

The system is UKCA approved and ISO 13845 certified, with FDA 510(k) applications currently in progress. 

“We did not have a UK ECG manufacturer and reporter until now,” said Professor Rameen Shakur, Founder of Cambridge Heartwear. “HeartSense® is the world’s first medical-grade, AI-powered, multi-channel ECG wearable and demonstrates what can be achieved when clinicians, engineers and AI specialists work together. We want to help move healthcare towards earlier diagnosis, better prevention and improved outcomes for patients across the NHS.” 

The partnership with the NHS Supply Chain allows Integrated Care Boards to deploy HeartSense® at scale, supporting the delivery of diagnostic-quality heart monitoring beyond hospital environments. The initiative is intended to reduce pressure on secondary care services while improving access to high-quality cardiac diagnostics in community settings. 

Founded by Professor Rameen Shakur, Cambridge Heartwear is a medical technology company based at Cambridge Science Park coming out of the University of Cambridge dedicated to making heart health monitoring simple, accessible and accurate. Combining medical research, engineering excellence and artificial intelligence, the company develops advanced wearable technologies that empower patients and healthcare professionals with diagnostic-quality cardiovascular insights anytime, anywhere. HeartSense® helps detect heart conditions earlier, enabling more informed clinical decision-making and better patient care.

Contact: info@camheartwear.com

CAMBRIDGE, England, Oct. 7, 2026 /PRNewswire/ — Cambridge Heartwear® Limited (www.camheartwear.com) has secured a landmark £184 million tender with the National Health Service (NHS) of the UK for HeartSense®, the world’s first medical-grade, multi-channel, portable, wirelessly charged ECG wearable straight to one’s mobile phone, representing a significant advancement in global Medical technology, AI application and cardiovascular diagnostics. 

The agreement with the UK National Health Service Supply chain enables the deployment of advanced cardiac monitoring technology across primary and secondary care and civil service departments, empowering patients to diagnose heart rhythm problems whenever and wherever they are to prevent heart failure and strokes earlier, reduce waiting times and support a more preventative approach to Heart Disease, which can take place in the comfort of their own homes. 

HeartSense® is the world’s first wearable to combine diagnostic-grade multi-channel ECG monitoring, adaptive artificial intelligence and wireless charging in a single device. Manufactured to bridge the gap in women’s cardiovascular care with its ergonomic design, the technology gives healthcare professionals and patients access to continuous, real-time ECG data on a mobile phone. giving you back the control of your health at every stage. 

Engineered in Cambridge and manufactured in Britain, HeartSense® has been developed to help identify cardiovascular disease and stroke risk before conditions become acute. Its proprietary engineering and AI technology with (86 patents ) support earlier intervention, enabling clinicians to make more informed decisions and improve patient outcomes. 

The system is UKCA approved and ISO 13845 certified, with FDA 510(k) applications currently in progress. 

“We did not have a UK ECG manufacturer and reporter until now,” said Professor Rameen Shakur, Founder of Cambridge Heartwear. “HeartSense® is the world’s first medical-grade, AI-powered, multi-channel ECG wearable and demonstrates what can be achieved when clinicians, engineers and AI specialists work together. We want to help move healthcare towards earlier diagnosis, better prevention and improved outcomes for patients across the NHS.” 

The partnership with the NHS Supply Chain allows Integrated Care Boards to deploy HeartSense® at scale, supporting the delivery of diagnostic-quality heart monitoring beyond hospital environments. The initiative is intended to reduce pressure on secondary care services while improving access to high-quality cardiac diagnostics in community settings. 

Founded by Professor Rameen Shakur, Cambridge Heartwear is a medical technology company based at Cambridge Science Park coming out of the University of Cambridge dedicated to making heart health monitoring simple, accessible and accurate. Combining medical research, engineering excellence and artificial intelligence, the company develops advanced wearable technologies that empower patients and healthcare professionals with diagnostic-quality cardiovascular insights anytime, anywhere. HeartSense® helps detect heart conditions earlier, enabling more informed clinical decision-making and better patient care.

Contact: info@camheartwear.com